Telangiectasia refers to persistently widened superficial blood vessels that become visible through the skin as fine red lines, branches, spots or vascular networks. The common phrase “broken capillaries” is imprecise because these vessels are usually dilated rather than literally ruptured.
Many isolated telangiectases are harmless cosmetic findings, especially on the face, but vessel color, pattern, distribution and associated symptoms can point toward rosacea, chronic sun damage, medication effects, venous disease or a systemic vascular disorder. Evaluation and treatment should therefore start by identifying the vessel pattern and likely cause.
This article is for educational purposes only. Multiple new, repeatedly bleeding or unusual telangiectases—especially with recurrent nosebleeds, anemia, skin tightening or a changing skin lesion—should be medically evaluated.
What Is Telangiectasia and What Do Visible Skin Blood Vessels Look Like?
Telangiectasia is persistent dilation of small superficial blood vessels that makes them visible as fine red lines, branches, clusters or vascular networks through the skin.
What Happens to the Blood Vessels in Telangiectasia?
A superficial small vessel remains widened, increasing its visible diameter so it can be seen through the overlying skin.
The key structural sequence is simple: a superficial vessel becomes persistently dilated, its caliber becomes easier to see, and a visible telangiectatic line or network appears.
Are Telangiectases Really “Broken Capillaries”?
No. “Broken capillaries” is a common lay term, but telangiectases are generally persistently dilated visible vessels rather than vessels that have literally ruptured.
This distinction matters because treatment is aimed at closing or reducing an abnormally visible vessel, not repairing a capillary tear.
What Do Typical Telangiectases Look Like?
Typical telangiectases appear as fine red linear vessels, branching lines, small vascular spots or clustered networks near the skin surface.
They may be linear, arborizing, mat-like or clustered, and their prominence can vary with skin tone, vessel depth and background redness.
Where Can Telangiectasia Develop?
Telangiectases can occur on many body sites but are especially noticeable on the face, nose, cheeks, lips, hands, legs, mucous membranes and the visible surfaces of the eyes.
Distribution is clinically useful because a central facial pattern, hand-and-face mats, mucosal lesions and leg venules each suggest different causes.
How Is Telangiectasia Different From a Spider Angioma?
Telangiectasia is a broad description of visible dilated superficial vessels, while a spider angioma is a specific vascular pattern with a central feeding arteriole and fine radiating branches.
A single spider angioma can be harmless, so its characteristic central-radial architecture should be identified before systemic meaning is assigned.
How Is Telangiectasia Different From Spider Veins?
Fine red superficial telangiectatic vessels differ from blue or purple visible venules, which are more accurately called venulectasia or spider veins.
Blue-purple networks on the legs are more venous in character and may require a venous-treatment approach rather than the same strategy used for fine facial red vessels.
What Causes Telangiectasia and Which Local or Systemic Conditions Can Be Associated With It?
Telangiectasia can develop from common local factors such as aging, sun damage, rosacea or corticosteroid exposure, but multiple or unusually distributed vessels can also accompany systemic or inherited disease.
What Common Acquired Factors Cause Telangiectasia?
Common acquired causes include aging, chronic sun exposure, pregnancy, rosacea, prior skin injury, radiation effects and prolonged corticosteroid exposure.
These factors do not all act through the same mechanism, so clinical history and distribution remain important.
How Is Facial Telangiectasia Related to Rosacea?
Rosacea can cause persistent central facial redness together with visible superficial vessels, particularly across the cheeks and nose.
For readers whose facial vessels occur with recurrent flushing, inflammatory bumps or chronic central facial redness, the Rosacea page owns the broader inflammatory disease and its treatment.
How Does Sun Damage Contribute to Visible Blood Vessels?
Chronic UV exposure can damage skin and vascular-support structures, making superficial vessels increasingly visible over time.
This is a cumulative photodamage concept; one episode of sunburn does not automatically create permanent telangiectasia.
Can Long-Term Steroid Cream Use Cause Telangiectasia?
Yes. Prolonged topical corticosteroid exposure can thin the skin and make superficial blood vessels more visible.
Systemic corticosteroids and intralesional corticosteroid exposure can also contribute in some settings, but prescribed treatment should be reviewed with a clinician rather than stopped abruptly.
Which Systemic Diseases Can Be Associated With Telangiectasia?
Telangiectasia can accompany systemic sclerosis, cutaneous lupus, dermatomyositis, liver disease, Cushing syndrome, hereditary hemorrhagic telangiectasia and selected inherited vascular disorders.
The presence of one isolated facial vessel is not enough to diagnose any of these conditions.
Why Can Systemic Sclerosis Cause Telangiectasia?
Systemic sclerosis can produce clustered dilated small vessels on the face, chest, palms and hands, especially when Raynaud phenomenon and skin tightening are also present.
When visible vessels occur with tight skin, sclerodactyly or Raynaud-type symptoms, the Scleroderma page provides the better-owner context for systemic sclerosis.
Can Lupus Cause Telangiectatic Vascular Changes?
Yes. Cutaneous and systemic lupus can be associated with vascular skin changes, but isolated telangiectasia does not establish lupus.
If visible vessels occur with photosensitive lupus-type eruptions or systemic autoimmune findings, the Lupus Erythematosus page owns the systemic-disease context.
When Does Hereditary Hemorrhagic Telangiectasia Become a Concern?
Hereditary hemorrhagic telangiectasia becomes more concerning when multiple characteristic telangiectases occur with recurrent spontaneous nosebleeds, family history or known internal vascular malformations.
Characteristic sites include the lips, mouth, fingers and nose. A single visible facial vessel is not enough to diagnose HHT.
How Is Telangiectasia Diagnosed and When Is Further Testing Needed?
Telangiectasia is usually diagnosed clinically from vessel color, pattern and distribution, while blood tests or imaging are reserved for cases with bleeding, family history or systemic features suggesting an underlying disorder.
How Does a Dermatologist Diagnose Telangiectasia?
Clinical assessment focuses on vessel appearance, color, pattern, body location, duration, medication history, sun exposure and associated symptoms.
Because telangiectasia is a visible vascular sign rather than one disease, the surrounding clinical context determines whether it is simply documented or investigated further.
Why Is Body Distribution Important?
Distribution helps narrow the cause because facial vessels, hand-and-face mats, mucosal vessels and leg venules each suggest different diagnostic pathways.
Central facial vessels can fit rosacea or photodamage, hand-and-face mats with Raynaud and tight skin raise systemic-sclerosis concern, mucosal vessels plus recurrent epistaxis raise HHT concern, and leg venules suggest venous disease.
When Are Blood Tests, Liver Tests or Imaging Needed?
Most isolated cosmetic facial telangiectases need no systemic testing, but investigation becomes appropriate when bleeding, systemic symptoms, family history or unusual distribution suggests another disease.
Depending on the suspected condition, clinicians may use targeted blood studies, liver testing or imaging rather than ordering the same test panel for every visible vessel.
Can a Skin Tumor Have Visible Telangiectatic Vessels?
Yes. Visible vessels can occur within certain tumors, so a raised, changing, ulcerated or persistently bleeding lesion should not be classified as harmless telangiectasia from the vessels alone.
A persistent pearly, ulcerated or otherwise suspicious lesion with surface vessels belongs in the differential of Basal Cell Carcinoma, where the lesion itself—not the telangiectasia—is the diagnostic target.
A rapidly enlarging firm skin tumor can also show surface vascularity; the Merkel Cell Carcinoma page owns that uncommon but important tumor-specific context.
When Should Telangiectasia Be Distinguished From a Skin Lesion Rather Than a Vessel Pattern?
When the visible vessel sits inside a raised, crusted, ulcerated, changing or structurally abnormal lesion, the underlying lesion—not the vessel alone—should drive diagnosis.
Cosmetic vessel treatment should not be used to bypass evaluation of a changing lesion.
How Is Telangiectasia Treated?
Telangiectasia treatment is optional for many harmless vessels and should be chosen according to vessel type and location, using options such as vascular laser, IPL, electrosurgery or sclerotherapy where appropriate.
Does Telangiectasia Always Need Treatment?
No. Stable, asymptomatic telangiectases can often be left untreated unless the appearance is bothersome, bleeding occurs or an underlying disease requires management.
Observation is therefore a valid option rather than a treatment failure.
How Do Vascular Lasers Treat Telangiectasia?
Vascular lasers target blood within selected superficial vessels, causing controlled vessel injury so the treated vessel gradually becomes less visible.
Choice of device depends on vessel size, depth, color, site, skin characteristics and clinician expertise; complete clearance should not be promised.
How Does IPL Treat Facial Telangiectasia?
Intense pulsed light uses filtered broadband light to reduce selected superficial vessels and vascular redness, particularly in suitable facial patterns.
IPL is a light-based device rather than a laser, and response varies with the vascular pattern and operator technique.
When Is Electrosurgery Used?
Electrosurgery can selectively destroy small visible superficial vessels when their size and distribution make this technique appropriate.
Because pigment change and scarring are possible with vascular procedures, treatment choice should account for skin type and operator experience.
When Is Sclerotherapy Used?
Sclerotherapy is used mainly for telangiectatic leg veins by injecting a sclerosant that injures the targeted venous channel so it collapses and becomes less visible.
Leg venules therefore have a more venous-treatment pathway, while fine facial red telangiectasia is more often treated with laser, light or selected electrosurgical techniques.
Why Must the Underlying Cause Be Treated Too?
Removing a visible vessel does not correct an ongoing driver such as rosacea, steroid-related skin damage, venous disease or systemic vascular disease.
The most durable strategy combines vessel-directed treatment, when desired, with management of the condition that keeps producing new visible vessels.
Can Telangiectasia Return, and When Should Visible Blood Vessels Be Medically Evaluated?
Treated vessels may remain reduced, but new telangiectases can develop if the underlying tendency persists, and multiple, bleeding or systemically associated vessels should be evaluated before further cosmetic treatment.
Can Telangiectasia Return After Laser or IPL?
Treated vessels may stay reduced for years, but new visible vessels can form elsewhere when rosacea, sun damage or another underlying tendency continues.
This is why successful treatment of one set of vessels does not equal permanent prevention of all future telangiectasia.
Can Sun Protection Reduce New Facial Telangiectasia?
Reducing chronic UV exposure may help limit one modifiable contributor to acquired facial telangiectasia and is particularly sensible after laser or light procedures.
Photoprotection should be layered rather than treated as a guarantee that no new vessels will appear.
Can Telangiectasia Be Completely Prevented?
No. Aging, pregnancy, inherited vascular disorders and systemic disease can produce telangiectasia even when modifiable risk factors are addressed.
Prevention therefore focuses on reducing controllable drivers rather than promising complete prevention.
When Should Telangiectasia Be Checked by a Doctor?
Medical assessment is appropriate when telangiectases appear suddenly in large numbers, repeatedly bleed, spread without explanation or occur with systemic or family-history clues.
Important patterns include recurrent spontaneous nosebleeds, oral or nasal telangiectases, unexplained anemia, Raynaud phenomenon, skin tightening, liver-related symptoms or a strong family history of HHT.
When Is a Changing Lesion With Visible Vessels More Concerning?
A raised, crusted, ulcerated, enlarging or changing lesion containing visible vessels should be assessed as a skin lesion rather than dismissed as simple telangiectasia.
Stable isolated vessels can be observed or treated cosmetically, but bleeding/systemic patterns should be investigated first and changing lesions need diagnostic reassessment.
What Should You Remember About Telangiectasia?
Telangiectasia is persistent superficial vessel dilation, and the correct approach is to identify the vessel pattern, understand why it is present and then decide whether observation, cosmetic treatment or systemic evaluation is appropriate.
- Telangiectasia means visible persistently dilated superficial vessels.
- “Broken capillaries” is an imprecise description.
- Telangiectases may be linear, branching, clustered or mat-like.
- Fine red telangiectasia differs from blue-purple venulectasia or spider veins.
- A spider angioma is a specific central-vessel-and-radiating-branches pattern.
- Many isolated telangiectases are harmless.
- Rosacea is a common facial context but not the only cause.
- Chronic UV exposure and aging can contribute.
- Prolonged corticosteroid exposure can make superficial vessels more visible.
- Systemic sclerosis, lupus, dermatomyositis, liver disease and HHT are selected systemic associations.
- Recurrent spontaneous nosebleeds plus mucocutaneous telangiectases and family history increase concern for HHT.
- Distribution helps identify the likely cause.
- Most isolated cosmetic facial vessels do not need systemic testing.
- Blood tests and imaging are targeted to systemic clues rather than ordered routinely.
- Visible vessels inside a changing tumor-like lesion require lesion-focused evaluation.
- Stable vessels may need no treatment.
- Vascular laser and IPL are common options for suitable facial vessels.
- Electrosurgery can treat selected isolated vessels.
- Sclerotherapy is particularly relevant to leg venules.
- Treating the underlying driver matters as much as closing the visible vessel.
- New vessels can develop after successful treatment.
- Complete prevention cannot be guaranteed.
- Repeated bleeding, systemic symptoms or a changing lesion should prompt medical assessment.
Frequently Asked Questions About Telangiectasia
The main telangiectasia questions concern spider veins, facial causes, rosacea, laser durability and signs of underlying disease.
Is Telangiectasia the Same as Spider Veins?
Not exactly. Fine red telangiectases are persistently dilated superficial small vessels, while blue or purple visible venules—especially on the legs—are more accurately described as venulectasia or spider veins.
What Causes Telangiectasia on the Face?
Facial telangiectasia can develop with rosacea, chronic sun damage, aging, steroid-related skin thinning and several other local or systemic factors.
Can Rosacea Cause Permanent Visible Blood Vessels?
Yes. Rosacea can produce persistent superficial facial vessels that may remain visible unless the underlying rosacea and the vessels themselves are treated.
Can Laser Treatment Permanently Remove Telangiectasia?
Laser can close some treated vessels for a long time, but new telangiectases can form later if the underlying vascular tendency or trigger persists.
When Can Telangiectasia Be a Sign of an Underlying Disease?
Underlying disease becomes more concerning when vessels are numerous, unusually distributed or associated with recurrent bleeding, anemia, Raynaud phenomenon, skin tightening, liver-related symptoms or a strong family history.
DermNet — Telangiectasia. Supports the definition, red-versus-blue vessel terminology, acquired and systemic causes, medication associations, tumor-related telangiectasia and treatment options including laser, IPL, electrosurgery and sclerotherapy.
MedlinePlus — Telangiectasia. Supports visible widened superficial-vessel framing, common body sites, usual harmlessness, selective testing when systemic disease is suspected, and facial laser versus leg sclerotherapy context.
American Academy of Dermatology — Lasers and Lights for Rosacea. Supports laser/light treatment for persistent facial vessels, the possibility of new vessels forming later and the importance of sun protection after procedures.
American Academy of Dermatology — Scleroderma Signs and Symptoms. Supports visible superficial vessels on the hands and face as part of systemic-sclerosis skin disease and their relationship to other vascular manifestations.
CureHHT — HHT Diagnostic Criteria. Supports the HHT pattern of recurrent spontaneous epistaxis, characteristic mucocutaneous telangiectases, internal vascular malformations and family history.
DermNet — Spider Telangiectasis. Supports the structural distinction between general telangiectasia, spider angioma and blue venous spider veins.
